Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Sharon Gardner"'
Autor:
Cara F Levitch, Whitney Guerry, Sharon Gardner, Jonathan L. Finlay, Stephen A. Sands, Benjamin Malkin, Lauren Latella
Publikováno v:
Neurooncol Pract
Background The Head Start treatment protocols have focused on curing young children with brain tumors while avoiding or delaying radiotherapy through using a combination of high-dose, marrow-ablative chemotherapy and autologous hematopoietic cell tra
Autor:
Jason Fangusaro, Joseph Stanek, Ira J. Dunkel, Sharon Gardner, Tom B. Davidson, Mohamed S. AbdelBaki, Jonathan L. Finlay, Mohammad H Abu-Arja, Girish Dhall
Publikováno v:
Neuro-Oncology
BACKGROUND We report the outcomes of patients with pineoblastoma enrolled on the Head Start I-III trials. METHODS Twenty-three children were enrolled between 1991–2009. Treatment included maximal surgical resection followed by five cycles of intens
Publikováno v:
Pediatric Blood & Cancer. 62:1403-1408
Background Approximately one in 285 children will be diagnosed with cancer before reaching their 20th birthday. While both oncologists and parents report a preference that these children die at home rather than in a hospital, there are limited data e
Autor:
Stephen A. Sands, Christina G. Salley, Juliette Hukin, Judith D. Goldberg, Sharon Gardner, Aniket Saha, Jonathan L. Finlay, Suzanne Scott, Randal Olshefski, Linda Rolnitzky, Preeti Saigal
Publikováno v:
Pediatric Blood & Cancer. 61:1644-1672
Background Due to the devastating late effects associated with cranial irradiation in young children with central nervous system (CNS) tumors, treatment for these patients has evolved to include the use of intensive chemotherapy to either avoid or po
Autor:
Aniket Saha, Sharon Gardner
Publikováno v:
Current Cancer Therapy Reviews. 9:126-136
Autor:
Jonathan L. Finlay, Ira J. Dunkel, Sharon Gardner, Keith P. Pasichow, Rebecca A. Weiss, Stephen A. Sands, James Garvin
Publikováno v:
Journal of Neuro-Oncology. 101:287-295
To evaluate the Quality of Life (QoL) and Social-Emotional/Behavioral functioning of survivors treated on the "Head Start I" protocol at participating medical centers across the United States between 1991 and 1997. Parents of 25 of 27 (92.5%) patient
Autor:
Sharon Gardner
Publikováno v:
Pediatric Transplantation. 8:28-32
Brain tumors are the second most common malignancy in children and the most common solid tumor. The majority of children are treated with surgery alone or in combination with radiation and/or chemotherapy. Recently investigators have used high dose c
Autor:
Matthias A. Karajannis, Uri Tabori, Darell D. Bigner, Sharon Gardner, Sandra E. Dunn, Ella Kumirova, Scott L. Pomeroy, Michael D. Taylor, Marc Remke, Claudia C. Faria, Roger J. Packer, Nada Jabado, Stefan M. Pfister, Yoon Jae Cho, Jaume Mora, Roger E. McLendon, Kari Elise T. Codispoti, Marcel Kool, Marina Ryzhova, Olga Zheludkova, Joanna Triscott, Andrew W. Walter, Sofia Nunes, Eric S. Lipp, Jad Alshami, Betty Luu, Cynthia Hawkins, Adam M. Fontebasso, David T.W. Jones, David Zagzag, James T. Rutka, Keith L. Ligon, Ulrich Schüller, José Pimentel, Paul A. Northcott, Maryam Fouladi, Sidney Croul, Eric Bouffet, Sridharan Gururangan, Andrey Korshunov, Adrian M. Dubuc, David Shih, Vijay Ramaswamy, Sébastien Perreault
Recurrent medulloblastoma is a therapeutic challenge because it is almost always fatal. Studies have confirmed that medulloblastoma consists of at least four distinct subgroups. We sought to delineate subgroup-specific differences in medulloblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b97535f276cf9e20199ea75773fd0f15
https://europepmc.org/articles/PMC3953419/
https://europepmc.org/articles/PMC3953419/
Autor:
Jonathan L. Finlay, Kevin C. De Braganca, Arnab Charkavarti, Stephen Sands, Minesh Mehta, Karla Bellman, Sharon Gardner, Michael Prados, Anita Mahajan, Roger Packer
Publikováno v:
Neuro-Oncology. 17:viii16.2-viii16
Autor:
David Mitchell, Michael A. Pulsipher, Haydar Frangoul, Shalini Shenoy, Gregory A. Yanik, Sandeep Soni, Morton J. Cowan, Douglas S. Taylor, Sharon Gardner, Michael Nieder, Richard Kadota, Edwin M. Horwitz, Rakesh K. Goyal, Allen R. Chen, Ann E. Haight, Mitchell S. Cairo, Laurence J.N. Cooper, Kirk R. Schultz, David A. Jacobsohn
Advances in pediatric bone marrow transplantation (BMT) are slowed by the small number of patients with a given disease who undergo transplantation, a lack of sufficient infrastructure to run early-phase oncology protocols and studies of rare nonmali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49a5d2feb3addef741a6511c1462e039
https://europepmc.org/articles/PMC2891395/
https://europepmc.org/articles/PMC2891395/